Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidrug-Resistant Tuberculosis in Central and Eastern Europe: Implementation and Maturity of Whole-Genome Sequencing for Surveillance.

Diseases (Basel, Switzerland)·2026
Same author

A multinational Delphi consensus on tuberculosis screening of migrants in Europe.

ERJ open research·2025
Same author

Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310.

The Lancet regional health. Europe·2025
Same author

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study.

The Lancet regional health. Europe·2025
Same author

DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis.

BMC infectious diseases·2025
Same author

Artificial intelligence: a useful tool in active tuberculosis screening among vulnerable groups in Romania - advantages and limitations.

Frontiers in public health·2025

Related Experiment Video

Updated: May 20, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Tuberculosis continues to be a concern].

Elmira Ibraim1, Nicoleta Cioran, Horia Cocei

  • 1Institutul de Pneumologie "Marius Nasta" - Programul National de Control al Tuberculozei, Bucureşti. ielmira2000@yahoo.com

Pneumologia (Bucharest, Romania)
|July 13, 2012
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) trends are favorable in Romania, with decreased cases and mortality. However, TB-HIV co-infection and drug-resistance remain significant challenges, particularly in vulnerable populations.

Related Experiment Videos

Last Updated: May 20, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Context:

  • Tuberculosis (TB) remains a global health concern with no regions fully free of the disease.
  • Romania has observed favorable TB trends between 2002 and 2011, including reduced incidence and mortality rates.
  • Specific demographics, such as men in rural areas aged 45-54, face the highest TB risk.

Purpose:

  • To analyze the epidemiological trends of Tuberculosis in Romania.
  • To identify high-risk populations and geographical areas within Romania.
  • To evaluate the effectiveness of the National TB Programme and highlight current challenges.

Summary:

  • From 2002 to 2011, Romania saw significant decreases in TB: new cases/relapses dropped by 13,235, incidence by 42%, child incidence by 51%, and mortality by 44%.
  • High TB incidence is noted in South-Western Romania, affecting men in rural settings, aged 45-54.
  • Effective TB control was achieved through over 70% case detection and 80% treatment success rates.

Impact:

  • Despite progress, TB-HIV co-infection and multidrug-resistant TB (MDR-TB) are major concerns.
  • Severe TB forms, including TB-HIV and MDR-TB, continue to affect children under 15.
  • Sustained TB control requires a multi-sectoral approach, integrating health services with social and economic support systems.